Eli Lilly and Company (LLY) Financial Statements

Comprehensive financial analysis for LLY including key ratios, revenue trends, profitability metrics, and analyst recommendations. Get detailed LLY financial performance analysis and investment insights.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio (TTM):43.23

Forward P/E:21.73

EPS (TTM):$15.28

Enterprise Value:$610.55B

Profitability Ratios

Profit Margin:25.91%

Return on Equity:86.29%

Return on Assets:16.55%

Operating Margin:45.80%

Financial Health

Current Ratio:1.28

Quick Ratio:0.51

Debt to Equity:217.89

Beta (5Y):0.44

Revenue and Profit Trends

Growth Metrics

Revenue Growth

37.60%

Earnings Growth

91.80%

Revenue Per Share

$59.22

Performance Metrics

Profit Margin Trend

25.91%

Return on Equity

86.29%

Return on Assets

16.55%

Analyst Insights

Price Targets

Average Target

$898.08

High Target

$1.19K

Low Target

$650.00

Analyst Recommendations

Recommendation

Buy

Analyst Coverage

26 Analysts

Upside Potential

+36.0%